SK Biopharmaceuticals...said on the 16th that its Japanese partner Ono Pharmaceutical obtained new drug approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for the epilepsy drug "Cenobamate (Japanese product name Xcopri)." (Chosun Biz) - Sep 16, 2026 - "The approval was based on the results of a multinational phase 3 trial conducted in Korea, China and Japan in adults with focal-onset seizures whose seizures were not controlled by existing antiepileptic treatments."
Japan approval • Epilepsy
|